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Abstract
Organ culture is an increasingly important tool in research, 
with advantages over monolayer cell culture due to the 
inherent natural environment of tissues. Successful organ 
cultures must retain cell viability. The aim of this study 
was to produce viable and non-viable osteochondral organ 
cultures, to assess the accumulation of soluble markers 
in the conditioned medium for predicting tissue viability. 
Porcine femoral osteochondral plugs were cultured for 
20 days, with the addition of Triton X-100 on day 6 (to 
induce necrosis), camptothecin (to induce apoptosis) or 
no toxic additives. Tissue viability was assessed by the 
tissue destructive XTT (2,3-bis[2-methoxy-4-nitro-5-
sulfophenyl]-2H-tetrazolium-5-carboxyanilide tetrazolium 
salt) assay method and LIVE/DEAD® staining of the 
cartilage at days 0, 6 and 20. Tissue structure was assessed 
by histological evaluation using haematoxylin & eosin 
and safranin O. Conditioned medium was assessed every 
3-4 days for glucose depletion, and levels of lactate 
dehydrogenase (LDH), alkaline phosphatase (AP), 
glycosaminoglycans (GAGs), and matrix metalloproteinase 
(MMP)-2 and MMP-9. Necrotic cultures immediately 
showed a reduction in glucose consumption, and an 
immediate increase in LDH, GAG, MMP-2 and MMP-9 
levels. Apoptotic cultures showed a delayed reduction 
in glucose consumption and delayed increase in LDH, 
a small rise in MMP-2 and MMP-9, but no significant 
effect on GAGs released into the conditioned medium. The 
data showed that tissue viability could be monitored by 
assessing the conditioned medium for the aforementioned 
markers, negating the need for tissue destructive assays. 
Physiologically relevant whole- or part-joint organ culture 
models, necessary for research and pre-clinical assessment 
of therapies, could be monitored this way, reducing the 
need to sacrifice tissues to determine viability, and hence 
reducing the sample numbers necessary.
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Introduction
There is a clinical need to develop more effective 
biomaterial and regenerative therapies for the repair and 
replacement of cartilage in articulating joints. Currently, 
there are many treatment options. These include hyaluronic 
acid injections, to supplement lubrication (Ayhan et al., 
2014); subchondral drilling, microfracture and abrasion 
arthroplasty to stimulate a fibrocartilage repair by bone-
derived multipotent stromal cells (Pridie, 1959; Steadman 
et al., 2001; Goyal et al., 2013a; Johnson, 1986; Steinwachs 
et al., 2008); autologous chondrocyte transplantation or 
matrix-enhanced chondrocyte implantation (Brittberg et 
al., 1994; Gillogly et al., 1998; Goyal et al., 2013b); and 
autologous or allogeneic osteochondral (OC) transplant 
(Goyal et al., 2014; Sherman et al., 2014). However, none 
of these treatments result in full restoration of hyaline 
cartilage function (Orth et al., 2014).
 The research and development of more effective 
cartilage substitution therapies would be greatly enhanced 
by the capacity to pre-clinically evaluate novel therapies in 
in vitro physiological tribological models of natural tissue 
articulations, for example of the natural tibio-femoral 
joint under dynamic loading. In order to develop such 
advanced physiological model systems, it will be necessary 
to develop systems for the organ culture of OC tissues, 
coupled with methods that allow on-line monitoring of 
the physiological status of the tissues.
 Ex vivo organ culture is increasingly being used in 
both fundamental and applied biomedical research, as it is 
much more representative of natural physiological cellular 
behaviour than simple monolayer culture. Organ culture 
has been employed in studies of meniscal tissue (Dai et 
al., 2013; Narita et al., 2009), articular cartilage (Jacoby 
and Jayson, 1976; Hollander et al., 1991; Fay et al., 2006; 
Tchetina et al., 2006), OC explants (Amin et al., 2009a; 
Seol et al., 2014), and whole porcine patellae (Ashwell et 
al., 2008; Ashwell et al., 2013). However, organ culture 
is extremely challenging, as conditions in these cultures 
must be able to maintain tissue viability and stable matrix 
composition. In order to monitor tissue viability in organ 
culture, tissues are sacrificed for analysis throughout the 
culture period, significantly reducing the sample number at 
each time point compared to the in situ monitoring situation 
where numbers are preserved.
 Cell viability is usually defined by plasma membrane 
integrity and/or the presence of metabolic activity. For cells 
in monolayer or suspension culture, dye exclusion such as 
Trypan blue (Pappenheimer et al., 1917) is commonly used, 
but this is not applicable to tissues. Cell tracker dyes such 
as 5-chloromethyl fluorescein diacetate (CMFDA) and 
propidium iodide (PI), calcein and ethidium homodimer, or 
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fluorescein diacetate and PI have been shown to be useful 
for monitoring cell viability, by labelling live and dead 
cells in tissues or engineered tissues, and localising them 
using confocal microscopy, but this is limited to tissues up 
to 4 mm in thickness (Amin et al., 2009b; Dai et al., 2013; 
Breuls et al., 2003).
 MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide) and XTT (2,3-bis-[2-methoxy-4-
nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxanilide 
tetrazolium salt) reduction assays, which measure cellular 
oxidative metabolism, also provide an accurate measure of 
tissue metabolism, but the process requires the destruction 
of the tissue (Mosmann, 1983; Roehm et al., 1991).
 Other methods of viability assessment include the 
terminal deoxynucleotidyl transferase dUTP nick end 
labelling (TUNEL) apoptosis assay (Mueller-Rath et al., 
2007; Narita et al., 2009; Seol et al., 2014), and histological 
analysis of cells and extracellular matrix (ECM) (Naqvi 
et al., 2005; Mueller-Rath et al., 2007; Dai et al., 2013), 
but these techniques require the tissues to be fixed and 
sectioned prior to the assay protocols. Apoptosis can also be 
assessed by measuring caspase 3/7 in whole tissue lysates, 
but again this requires destruction of the tissue (Dudli et 
al., 2012).
 Non-invasive, non-destructive methods to assess tissue 
viability have been reported, such as measurement of 
oxygen consumption by optical oxygen sensing (O’Riordan 
et al., 2000; Deshpande and Heinzle, 2004; Deshpande et 
al., 2004), and determination of carbon dioxide production 
(Yang and Balcarcel, 2004). However, these methods 
require the cultures to be sealed from ambient gases so that 
those gases cannot dissolve into the culture medium. Such 
sealing would be prohibitive to tissue survival in organ and 
tissue culture.
 Lactate dehydrogenase (LDH) release from damaged 
cells into the surrounding medium has been used to 
monitor cell death in culture as a non-invasive method 
of cell viability assessment (Racher et al., 1990; Wagner 
et al., 1991; Legrand et al., 1992). Similarly, online 
glucose monitoring has also been used to assess viable 
cell numbers in cell culture, with reduced consumption of 
glucose indicating reduced metabolism and cell death (Prill 
et al., 2014), although it has been reported that a loss of 
viability is not always indicated by a decrease in glucose 
consumption (Racher et al., 1990). Alkaline phosphatase is 
produced by osteoblasts and is potentially a good indicator 
of healthy viable bone.
 Methods for the non-invasive assessment of the 
integrity of the extracellular matrix of osteochondral tissues 
include the measurement of glycosaminoglycans (GAGs) 
and matrix metalloproteinases (MMPs) in the organ culture 
conditioned medium. Previous studies have measured the 
release of GAGs from organ cultures as an indicator of 
cartilaginous tissue degradation (Tchetina et al., 2006; 
Korecki et al., 2007). Both MMP-2 and MMP-9 have been 
shown to be elevated in the synovial fluid of rheumatoid 
arthritis patients (Cawston and Young, 2010), which might 
indicate that these MMPs are potential markers for the 
degradation of osteochondral tissues.
 The longer term aims of our studies are to develop 
physiological biotribological models of natural cartilage 
articulations, in order to investigate the impact of novel 
cartilage substitution therapies on the surrounding and 
opposing cartilage. Hence, the number of replicate 
organ cultures will be limited, negating the use of tissue 
destructive methods for determination of tissue viability 
during longer term culture. The aim of this study was 
therefore to investigate the utility of measuring a range 
of molecular markers in the organ culture conditioned 
medium as an indicator of tissue viability. We used 
Triton X-100 to induce cell necrosis by causing cell lysis 
and camptothecin to induce apoptosis by interfering 
with topoisomerase I enzymes, in porcine femoral OC 
organ cultures. We demonstrate that a combination of 
non-invasive analytical techniques that assess changes 
in glucose consumption, and release of LDH, alkaline 
phosphatase (AP), glycosaminoglycans (GAGs) and matrix 
metalloproteinases (MMPs) into the culture medium can 
be used to indicate changes in tissue viability, without 
sacrifice of the tissues.
Materials and Methods
Tissue procurement
Porcine hind legs were obtained from animals 4-6 months 
old from a local abattoir (J. Penny, Leeds, UK) within 4 h 
of sacrifice. Under aseptic conditions, all soft tissues were 
dissected from the femora, which were then clamped using 
a bench vice. A sterile 9 mm drill was then used to dissect 
OC plugs from the femoral condyles (Fig. 1a), to a depth 
of approximately 6 mm, and a sterile 9 mm corer used 
to release the plugs from the underlying bone. OC plugs 
were immediately stored in Hank’s balanced salt solution 
(HBSS; Sigma-Aldrich Company Ltd.; product code 
H8264) and transferred to a sterile class II cabinet. Sterile 
bone cutters were then used to trim the plugs to a depth of 
4-5 mm. Bone marrow was washed out with an overnight 
heparin (12.5 IU/mL; LEO Pharma, Hurley, UK; product 
code 009876-04) and antibiotic (200 U/mL penicillin/ 
200µg/mL streptomycin [Lonza, Walkersville, MD, 
USA; product code DE17-603E], 50 µg/mL gentamycin 
[Sigma-Aldrich Company Ltd., Dorset, UK; product code 
G1272] and 2.5 µg/mL amphotericin B [Sigma-Aldrich 
Company Ltd.; product code A2942]) wash in HBSS at 
4 °C and subsequent jet washing using phosphate buffered 
saline (PBS; Lonza; product code BE17-512F) with a 
Waterflosser Ultra (Waterpik International Inc., Surrey, 
UK; product code WP-120UK). OC plugs, before and after 
washing, are illustrated in Fig. 1b and c. OC plugs were 
washed again using PBS with a Waterflosser Ultra and 
washed twice for 5 min in HBSS before culture.
Organ culture
Tissues obtained from two animals were used in two 
separate experiments. OC plugs (n = 15; from the same 
animal) were weighed and 3 replicates were sacrificed 
for day 0 XTT assay. The remaining 12 were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM; Lonza; 
product code BE12-917F) supplemented with L-glutamine 
(2 mM; Lonza; product code BE17-605E), 100 U/mL 
penicillin/ 100 µg/mL streptomycin, gentamycin (50 µg/
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mL), amphotericin B (2.5 µg/mL), ascorbic acid (50 µg/
mL; Sigma-Aldrich Company Ltd.; product code A8960), 
dexamethasone (0.1 µM; Sigma-Aldrich Company Ltd.; 
product code D2915), and ITS™ premix universal culture 
supplement (0.1 % v/v; Corning B.V. Life Sciences, 
Amsterdam, The Netherlands; product code 354351) at 
37 °C in 5 % (v/v) CO2 in air. Culture medium was changed 
and conditioned medium collected at days 1, 3 and 6. At 
day 6, three OC plugs were sacrificed for XTT assay. Of the 
remaining nine OC plug cultures, three were spiked with 
camptothecin (4 µg/mL; Cayman Chemical Company, Ann 
Arbor, MI, USA; product code 11694), three were spiked 
with Triton X-100 (0.01 % [v/v]; Sigma-Aldrich Company 
Ltd.; product code X100), and three were cultured without 
any additional treatments for the remainder of the culture 
period. The medium was changed and conditioned medium 
collected on days 9, 13, 16 and 20. OC plugs cultured 
with camptothecin (n = 3), Triton X-100 (n = 3) or culture 
medium alone (n = 3) were sacrificed on day 20 for analysis 
by XTT assay. The study was repeated, with collection of 
the conditioned medium using a further n = 15 OC plugs 
from a different animal.
 In order to obtain tissue for histological evaluation and 
analysis of chondrocyte membrane integrity by LIVE/
DEAD® cell staining, OC plugs (n = 15) were placed into 
organ culture as described above. OC plugs were harvested 
at day 0 (n = 3) and day 6 (n = 3). Of the remaining OC 
plug cultures (n = 9), three were spiked with camptothecin 
(4 µg/mL), three were spiked with Triton X-100 (0.01 % 
(v/v)), and three were cultured without treatment for a 
further 14 days prior to harvest at day 20.
Assay of tissue viability
Tissue viability was analysed using an XTT based in 
vitro toxicology assay kit (Sigma-Aldrich Company Ltd.; 
product code TOX-2), with some small adaptations to the 
manufacturer’s instructions. Briefly, pre-weighed tissues 
(bone or cartilage) were chopped into approximately 
2 mm3 pieces using a scalpel and incubated in the XTT 
solution (1 mL) for 4 h at 37 °C in 5 % (v/v) CO2 in air 
and the XTT solution removed and retained. Tetrazolium 
product was then extracted from the tissues with dimethyl 
sulfoxide (DMSO; 0.5 mL; VWR Chemicals, Lutterworth, 
UK; product code 23500.297) for 1 h. XTT and DMSO 
solutions were then pooled before reading the absorbance 
of triplicate samples at 450 nm and 690 nm in a 96 well 
plate (Nunc A/S [Thermo Fisher Scientific], Roskilde, 
Denmark; product code 269620) using a microplate 
spectrophotometer (Thermo Scientific, Fisher Scientific, 
Loughborough, UK; model Multiskan Spectrum) and 
SkanIt™ RE for MSS 2.1 software (Thermo Software, 
Thermo Scientific). The absorbances at 690 nm were 
subtracted from those at 450 nm and XTT content 
calculated per gram of tissue.
LIVE/DEAD cell staining of cartilage tissues
Plasma membrane integrity of the chondrocytes in the 
cartilage of the OC plugs was visualised using LIVE/
DEAD® cell staining (Life Technologies). A cross-sectional 
slice of the cartilage was cut using a scalpel (< 1mm). 
LIVE/DEAD® working solution (1 µM calcein-AM and 
1 µM ethidium homodimer-1 in PBS) was added to the 
cartilage slice and incubated at 37 °C in 5 % (v/v) CO2 
in air for 1 h. The cartilage slice was washed three times 
in PBS before imaging by confocal microscopy (Zeiss 
LSM510 Meta).
Histological evaluation of cartilage tissues
For histological evaluation, the cartilage was sliced from 
the bone of the OC plugs using a scalpel. The cartilage 
samples were fixed in 10 % (v/v) neutral buffered formalin 
(Atom Scientific) for 48 h and dehydrated through 
Fig. 1. Images of the osteochondral tissues. Porcine femoral head (a) from which 9 mm diameter osteochondral plugs 
were dissected (b). The plugs were washed to remove all blood and marrow (c).
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increasing concentrations of ethanol followed by xylene 
and embedded in paraffin wax. Serial sections (5 µm) were 
stained with haematoxylin and eosin (H&E) or safranin O. 
For safranin O staining, sections were rehydrated, stained 
with Weigerts` haematoxylin (Atom Scientific) for 3 min, 
differentiated in 1 % (v/v) acid alcohol, stained with 
0.02 % (w/v) aqueous fast green (Sigma) for 5 min and 
washed briefly in 1 % (v/v) acetic acid before staining in 
0.1 % (w/v) safranin O (Acros) for 4 min. Sections were 
dehydrated and mounted. Images were captured using an 
upright Carl Zeiss Axio Imager.M2 incorporating an Axio 
Cam MRc5, which was controlled by Zen Pro software 
2012 (Zeiss).
Conditioned medium assays
All conditioned medium samples were analysed from 
the 20 day untreated control group (C), the group treated 
with Triton-X 100 (0.01 % [v/v]) from day 6 to 20 (TX), 
the group treated with camptothecin (4 µg/mL) from day 
6 to 20 (CA).
Glucose assay
Conditioned medium was analysed for glucose content 
using the GlucCell™ glucose monitoring system (Cesco 
Bioproducts, Atlanta, GA, USA; product code DG1000). 
Fresh and conditioned culture medium samples (30 µL) 
were pipetted onto a clean hydrophobic surface in duplicate 
and measured using glucose test strips (Cesco Bioproducts; 
product code DGA050) according to the manufacturer’s 
instructions. Average readings were used to calculate total 
glucose concentration in each sample. The concentrations 
of glucose in the conditioned medium were subtracted 
from the concentration of glucose in the fresh medium to 
determine the amount of glucose used (mg). This was then 
divided by the tissue weight (g) and again by the number 
of days in culture to give glucose (mg) utilised per gram 
of tissue per day in culture.
Lactate dehydrogenase (LDH) assay
LDH content in conditioned medium was measured 
using an LDH cytotoxicity assay kit (Cayman Chemical 
Company; product code 10008882) according to the 
manufacturer’s instructions. Triplicate conditioned medium 
samples were diluted in assay buffer to bring each within 
the linear region of the assay. LDH standard was serially 
diluted in assay buffer (containing fresh culture medium of 
the same dilution as the samples) to prepare standard LDH 
solutions in triplicate. Absorbance at 490 nm was measured 
in a 96 well plate, using a microplate spectrophotometer 
and SkanIt™ RE for MSS 2.1 software. Linear regression 
was performed on the absorbances of the standard LDH 
solutions and the LDH concentrations in the conditioned 
medium samples were calculated. Average readings were 
used to calculate the total LDH (mU) in each sample. This 
was then divided by the tissue weight (g) and by the number 
of days in culture to give LDH (mU) released per gram of 
tissue per day in culture.
Glycosaminoglycan (GAG) assay
Accumulation of sulphated GAGs was measured using a 
standard dimethylmethylene blue (DMMB) colourimetric 
assay (Farndale et al., 1986). Briefly, conditioned medium 
samples were diluted in assay buffer to bring each within the 
linear region of the assay. Chondroitin sulphate B standard 
(Sigma-Aldrich Company Ltd.; product code C3788) was 
serially diluted in assay buffer (containing fresh medium 
at the same dilution as the samples) to prepare standard 
GAG solutions. Diluted samples and standards (40 µL) 
were mixed with DMMB solution (250 µL) in triplicate in 
96 well plates. After 2 min of shaking the plate, absorbance 
at 525 nm was read using a microplate spectrophotometer 
and SkanIt™ RE for MSS 2.1 software. Linear regression 
was performed on the absorbances of the standard GAG 
solutions and the GAG concentrations in the conditioned 
medium samples were calculated. Average readings were 
used to calculate the total amount of GAGs (µg) in each 
sample. This was then divided by the tissue weight (g) and 
by the number of days in culture to give GAG (µg) released 
per gram of tissue per day in culture.
Alkaline phosphatase (AP) assay
AP content in conditioned medium was measured using 
the colorimetric SensoLyte® pNPP Alkaline Phosphatase 
Assay Kit (AnaSpec Inc., Fremont, CA, USA; product 
code 72146) according to the manufacturer’s instructions. 
Triplicate conditioned medium samples were diluted in 
assay buffer to bring each within the linear region of the 
assay. AP standard was serially diluted in assay buffer 
(containing fresh medium at the same dilution as the 
samples) to prepare standard AP solutions in triplicate. 
Absorbance at 405 nm was measured using a microplate 
spectrophotometer and SkanIt™ RE for MSS 2.1 software. 
Linear regression was performed on the absorbance 
readings obtained from the standard AP solutions and AP 
concentrations in the conditioned medium samples were 
calculated. Average readings were used to calculate total 
AP (ng) in each sample. This was then divided by the tissue 
weight (g) and by the number of days in culture to give AP 
(ng) released per gram of tissue per day in culture.
Determination of MMP-2 and MMP-9 using gelatin 
zymography
MMP-2 and MMP-9 activity was assessed in the 
conditioned medium from 2 replicate samples of the 
repeat experiment at days 6, 9, 13 and 16 using gelatin 
zymography (Woessner, 1995). Conditioned medium 
samples were diluted in zymogram sample buffer (Bio-
rad Laboratories Ltd., Hemel Hempstead, UK; product 
code 161-0764) and electrophoresed under non-reducing 
conditions on pre-cast 10 % (w/v) SDS-PAGE gelatin 
zymography gels (Bio-rad Laboratories Ltd.; product 
code 161-1167). Gels were washed twice in zymogram 
renaturation buffer (Bio-rad Laboratories Ltd.; product 
code 161-0765) at 4 °C for 20 min each wash, before wash 
and overnight incubation at 37 °C in zymogram developing 
buffer (Bio-rad Laboratories Ltd.; product code 161-
0766) containing 1 mM 4-amino-phenylmercuric acetate 
(APMA; Sigma-Aldrich Company Ltd.; product code 
A9563). Gels were then stained with SimplyBlue™ Safe 
Stain (Invitrogen, Life Technologies Ltd., Paisley, UK; 
product code LC6065) for 3 h and de-stained overnight 
in distilled water to reveal zones of gelatinase activity. 
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The gels were analysed using an Evolution™ MP Colour 
camera and Image-Pro® Plus version 5 image analysis 
software (Media Cybernetics Inc., Rockville, MD, USA).
Statistical analysis
All data were analysed by one-way ANOVA followed 
by Tukey’s multiple comparison test (GraphPad Prism 6, 
GraphPad Software, San Diego, CA, USA). Results are 
reported as mean values +/- standard deviation or standard 
error and considered significant when p < 0.05.
Results
Viability of osteochondral tissue organ cultures over 
20 days
In the first experiment, XTT assays of tissue viability 
indicated that the cartilage tissue showed reduced XTT 
conversion from day 0 to 6 (p < 0.0001), but there was no 
further reduction in the amount of XTT converted by the 
tissue from day 6 to day 20 in the untreated control cultures 
(Fig. 2a). Therefore, XTT conversion by the control tissues 
remained stable between day 6 and day 20, the period 
when the test OC plugs were treated with either 0.01 % 
(v/v) Triton X-100 or 4 µg/mL camptothecin. The XTT 
assay data at day 20, showed that both Triton X-100 and 
camptothecin treatment from day 6 resulted in significant 
loss of XTT conversion by the cartilage tissue (p < 0.01 for 
Triton X-100 and p < 0.05 for camptothecin). The repeat 
study showed the same pattern of results for the cartilage 
tissue and the same significant differences between XTT 
conversion data at days 6 and 20, although the actual 
values for XTT conversion per gram of tissue were lower 
throughout (Fig. 2b).
 The bone tissue also showed a significant reduction 
in XTT conversion from day 0 to 6 in the first study 
(p < 0.01), with a subsequent significant increase to day 
20 (p < 0.05; Fig. 2c). Therefore, the ability of the bone 
to convert XTT appeared to recover from day 6 to 20 in 
the control group. Treatment of the OC plugs with 0.01 % 
(v/v) Triton X-100 or 4 µg/mL camptothecin, initiated at 
day 6, caused significant reductions in XTT conversion 
by the bone compared to the control at day 20 (p < 0.01). 
The repeat study showed a very similar range and pattern 
Fig. 2. Viability assessment of osteochondral tissues over 20 days in culture. XTT conversion by cartilage (a and b) 
and bone (c and d) over 20 days in two separate experiments using tissue from two porcine donors (a and c, tissue 
from porcine donor 1; b and d, tissue from porcine donor 2). XTT assays were used to assess the effects of 0.01 % 
Triton X-100 (TX) and 4 µg/mL camptothecin (CA), added at day 6 of culture, on tissue viability. The data are 
presented as the mean (n = 3) ± standard error. Data were analysed by one way ANOVA and significant differences 
are indicated by *p < 0.05, **p < 0.01, ****p < 0.0001.
361 www.ecmjournal.org
KM Elson et al.                                                                                              Monitoring of osteochondral organ culture
of results, although there was greater variation in the data 
(Fig. 2d). There were no significant changes in the amount 
of XTT converted between day 0, day 6 and day 20 in the 
control cultures, but at day 20 the Triton X-100 (0.01 % 
[v/v]) and camptothecin (4 µg/mL) treated organ cultures 
showed significantly less XTT conversion compared to 
day 0 (p < 0.05).
LIVE/DEAD® cell staining of cartilage tissues over 20 
days of organ culture
The plasma membrane integrity of the chondrocytes in 
the cartilage of the OC plugs was visualised using LIVE/
DEAD® cell staining. Images of the cross-sectional slices 
are presented in Fig. (3a). At day 0, whilst the majority of 
the chondrocytes in the tissue stained green – indicating 
viable cells, there was a band of dead cells in the cartilage 
surface zone. At day 6, most of the chondrocytes within 
the cartilage tissue were viable, again with a band of dead 
cells in the surface zone. For the control tissue at day 20, 
LIVE/DEAD® cell staining showed the same pattern, with 
most of the cells in the tissue remaining viable. This was 
in contrast to the images of the tissues treated with Triton 
X-100 or 4 µg/mL camptothecin at day 20. In tissues treated 
with Triton X-100, there were overall fewer cells and all 
the remaining cells were stained red, and therefore dead. In 
tissues treated with camptothecin, whilst there were some 
chondrocytes that retained membrane integrity throughout 
the cartilage, most of the cells were dead.
Fig. 3. LIVE/DEAD® cell imaging and histological evaluation of cartilage tissues over 20 days in culture. LIVE/
DEAD® stained images of slices of cartilage tissue from OC plug cultures; scale bar 500 µm (a); Sections of cartilage 
tissue from OC plug cultures stained with safranin O; scale bar 500 µm (b); High power images of sections of the 
mid-section of cartilage tissue from OC plug cultures stained with H&E; scale bar 100 µm (c). Control; no treatment 
after 6 days of culture. CA; treated with camptothecin (4 µg/mL) after 6 six days of culture. Triton X-100; treated 
with 0.01 % (v/v) after 6 days of culture.
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Histological evaluation of the osteochondral tissue 
cartilage over 20 days of organ culture
Images of sections of the cartilage tissues from the organ 
cultures stained with safranin O and H&E are shown in 
Fig. (3b) and (3c) respectively. Images of control tissue 
sections stained with safranin O revealed strong staining 
for GAGs at day 0 and day 6 with slight qualitative 
reduction in staining intensity at day 20. In the cartilage 
tissue treated with 4 µg/mL camptothecin at day 20, 
there was an apparent reduction in staining with safranin 
O compared to the control tissue at day 20, but GAGs 
were still present in the tissue. In sections of the cartilage 
tissue treated with Triton X-100 at day 20, there was no 
positive staining with safranin O indicating a complete 
loss of GAGs from the tissue. The H&E stained sections 
revealed that the cartilage tissue remained structurally 
intact regardless of the duration of organ culture or mode 
of treatment. The major difference in the tissues revealed 
by H&E staining of tissue sections was that in the tissues 
treated with TritonX-100 at day 20, there were numerous 
empty lacunae present compared to the control tissue at day 
20. This was not a feature of the tissue treated with 4 µg/
mL camptothecin at day 20 which was morphologically 
similar to the control tissue at day 20.
Glucose consumption by osteochondral tissue organ 
cultures over 20 days
In the control OC cultures there were significant reductions 
in glucose consumption from day 1 to 3 (p < 0.0001) 
and again from day 3 to 6 (p < 0.001), but there were 
Fig. 4. Glucose consumption of osteochondral tissues over 20 days in culture. Glucose assays were used to assess 
glucose consumption over 20 days of culture and the effects of 0.01 % Triton X-100 (TX) or 4 µg/mL camptothecin 
(CA), added at day 6 of culture, compared to untreated controls cultured for the whole culture period of 20 days (C), 
in two separate studies (a and b). The data are presented as the mean (n = 3) ± standard deviation. Data were analysed 
by one way ANOVA and significant differences are indicated by *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Fig. 5. LDH release by osteochondral tissues over 20 days in culture. LDH assays were used to assess LDH release 
over 20 days of culture and the effects of 0.01 % Triton X-100 (TX) or 4 µg/mL camptothecin (CA), added at day 6 
of culture, compared to untreated controls cultured for the whole culture period of 20 days (C), in two separate studies 
(a and b). The data is presented as the mean (n = 3) ± standard deviation. Data were analysed by one way ANOVA 
and significant differences are indicated by *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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no further changes in glucose consumption from day 6 
onwards, showing a steady consumption of glucose after 
an initial settling period. In both studies, there were no 
significant differences in glucose consumption between 
any groups before treatments began at day 6 (Fig. 4). 
Immediately after treatment at day 6, the Triton X-100 
treated OC tissues consumed significantly less glucose 
with a reduction in consumption at each subsequent time 
point from day 6 until negligible glucose consumption at 
day 13 (Fig. 4a) and 16 (Fig. 4b) in the first and second 
study respectively. The camptothecin-treated OC tissues 
also consumed significantly less glucose after treatment 
although the reduction in glucose consumption occurred 
over an extended period of time with consumption reducing 
over 2 time-points from day 6 to 13 in both studies and 
further reducing from day 9 to 16 and day 13 to 20 in the 
second study.
LDH release by osteochondral tissue organ cultures 
over 20 days
In both studies, there was a trend for higher LDH levels in 
the first 6 days of culture in all groups, followed by lower, 
constant levels in control cultures (Fig. 5). There were 
no significant differences in LDH concentrations in the 
culture fluids between groups before treatment at day 6. 
After treatment (day 9), the Triton X-100 treated OC plugs 
released significantly more LDH than the control OC plugs 
in both studies (p < 0.01 and p < 0.0001; Fig. 5a and 5b 
respectively). This peak in LDH release was short lived, 
with significantly less LDH released at day 13 compared 
to day 9 in both studies (p < 0.01 and p < 0.0001; Fig. 5a 
and 5b respectively). In the repeat study the camptothecin-
treated group released more LDH than the control group 
on day 13 (p < 0.001; Fig 5b), a peak that was short lived, 
being significantly higher than levels detected later at 
Fig. 6. GAG release by osteochondral tissues over 20 days in culture. GAG assays were used to assess GAG 
accumulation over 20 days of culture and the effects of 0.01 % Triton X-100 (TX) or 4 µg/mL camptothecin (CA), 
added at day 6 of culture, compared to untreated controls cultured the whole culture period of 20 days (C), in two 
separate studies (a and b). The data are presented as the mean (n = 3) ± standard deviation. Data were analysed by 
one way ANOVA and significant differences are indicated by *p < 0.05, ***p < 0.001, ****p < 0.0001.
Fig. 7. MMP release by osteochondral tissues over 20 days 
in culture. MMP-2 (doublet of pro-MMP-2 and active MMP-
2) and MMP-9 present in conditioned medium samples 
collected on days 6, 9, 13 and 16 of a 20 day culture, from 2 
samples each of the untreated (C), 0.01 % Triton X-100 (TX) 
or 4 µg/mL camptothecin (CA) groups. Treatments began 
after medium collection on day 6 of culture.
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day 16 (p < 0.05). This same pattern of LDH release was 
observed in the first study although the findings were not 
statistically significant due to larger variation in the data 
(Fig. 5a).
GAG release by osteochondral tissue organ cultures 
over 20 days
In both studies, the levels of GAGs released into the culture 
medium were relatively high and variable on day 1 in all 
groups, but then reduced and remained constant in the 
control group from day 3 onwards (Fig. 6). There were 
no significant differences in GAG concentrations in the 
culture fluids between groups before treatment at day 6. In 
both studies, the Triton X-100 treated OC plugs released 
significantly higher levels of GAGs immediately after 
treatment, from day 6 to 9 (p < 0.001 and p < 0.05; Fig. 
6a and 6b respectively). There was no significant effect of 
camptothecin on GAGs release by the OC plugs.
MMP-2 and MMP-9 release by osteochondral tissue 
organ cultures over 20 days
MMP-2 was detected in the culture medium as a doublet of 
pro-MMP-2 and active MMP-2 along with a single MMP-9 
band at approximately equal levels in all samples tested 
at day 6 before any treatments of the OC cultures (Fig. 7). 
At day 9, following treatment, levels of both MMPs were 
low in the untreated control OC plug cultures and appeared 
higher in the camptothecin-treated OC plug cultures, and 
even higher in the Triton X-100 treated OC plug cultures 
compared to the controls. MMP-2 was not detected at day 
13 in the control samples, but was present at day 16. Levels 
of MMP-2 reduced in the Triton X-100 samples from day 
9 to 16, and more active MMP-2 than pro-MMP-2 was 
detected in the camptothecin-treated cultures at days 13 
and 16. MMP-9 was barely detectable in any of the culture 
samples at days 13 and 16.
AP release by osteochondral tissue organ cultures 
over 20 days
In both studies there was an initial high level of AP 
detected in the culture fluids in all groups, which reduced 
significantly at day 3 (Fig. 8). From day 3 onwards, 
there was a general, but not significant, decline in AP 
concentration released into the culture medium in all 
OC plug cultures, regardless of treatment. No significant 
differences were found between treated and control OC 
plug cultures at any time point.
Discussion
Organ culture is very challenging in three main respects. 
Firstly, the researcher generally has a limited number of 
samples due to the practicalities of procuring sufficient 
tissue. Secondly, maintaining organ cultures in vitro, in the 
appropriate physiological environment, with an adequate 
oxygen and nutrient exchange system, is often limited. 
Thirdly, the researcher needs to be able to monitor the 
viability status of the organ culture, which usually requires 
harvesting replicate samples at given time intervals for 
analysis. The aim of this study was to evaluate the use 
of molecular markers in the conditioned medium of OC 
cultures as an indicator of the viability of the tissues, 
negating the need to sacrifice the tissue samples.
 In this study, porcine OC tissues were used. This 
was driven by the longer term aims to develop in vitro 
models that incorporate natural OC tissues for the pre-
clinical biotribological testing of novel biomaterial and 
regenerative therapies for cartilage repair and replacement 
within a range of diarthrodial joints including the knee, 
hip and spinal facet joints. The data will however, be of 
general interest to researchers engaged in organ culture of 
a range tissues.
Fig. 8. AP release by osteochondral tissues over 20 days in culture. AP assays were used to assess AP release over 
20 days of culture and the effects of 0.01 % Triton X-100 (TX) or 4 µg/mL camptothecin (CA), added at day 6 of 
culture, compared to untreated controls cultured for the whole culture period of 20 days (C), in two separate studies 
(a and b). The data are presented as the mean (n = 3) ± standard deviation. Data were analysed by one way ANOVA. 
No significant differences between the controls and treatment groups were detected.
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 Determination of the viability of cells in tissues in 
organ culture can be complex, since there are two modes 
of cell death – necrosis and apoptosis. Necrotic cells lose 
their membrane integrity in an uncontrolled manner, 
whilst apoptotic cells die through a controlled process that 
involves cell shrinkage, nuclear fragmentation, and the 
formation of apoptotic bodies (with no loss of membrane 
integrity), which are then removed by macrophages in vivo. 
Many assays of cell viability (dye exclusion, intracellular 
enzyme release) rely upon the necrotic loss of membrane 
integrity that is not seen with apoptosis. Assays that detect 
metabolic activity (glucose or oxygen consumption, carbon 
dioxide production, tetrazolium assays) are also only 
applicable to necrotic cells or those that have completed 
apoptosis, and do not detect the early apoptotic cells that 
are committed to die but are still metabolically active 
(Browne and Al-Rubeai, 2011). Furthermore, assays that 
detect apoptotic cells (e.g. TUNEL) do not detect necrotic 
cells or those apoptotic cells that have not yet commenced 
nuclear fragmentation (Browne and Al-Rubeai, 2011). In 
this study, a combination of non-invasive assays was used 
to assess tissue viability and ECM stability alongside the 
widely used, but tissue sacrificing, XTT assay.
 It was found that the OC cultures required a period 
of up to 6 days to equilibrate to the in vitro environment 
following harvesting. During this initial period of culture, 
there was a significant reduction in XTT conversion by 
both cartilage and bone tissues. This was followed by 
consistent values for XTT conversion by the untreated 
control OC tissues for up to 20 days of culture, indicating 
that tissues could be maintained in organ culture. The 
viability of the cartilage tissue in osteochondral plug 
organ cultures was also evaluated using LIVE/DEAD® 
staining. This revealed that at day 0, there was a band of 
dead cells in the superficial layer of the cartilage and that 
the majority of the chondrocytes in the middle and lower 
regions of the cartilage were alive. Exposure to the air and 
drying out of the cartilage surface during preparation for 
organ culture most likely accounted for the surface dead 
zone visible at day zero (Pun et al., 2006). After 6 and 20 
days (for the control OC plugs) in culture there was no 
noticeable change in the LIVE/DEAD® staining pattern of 
the cartilage tissue indicating that the chondrocytes within 
the cartilage did not lose membrane integrity in organ 
culture for up to 20 days. This suggested that the levels of 
XTT conversion observed in the OC organ cultures at day 
0 were elevated due to an initial increase in mitochondrial 
activity of the chondrocytes following harvest of the OC 
plugs and placement in organ culture, supporting the need 
for an equilibration period.
 This need for an equilibration period was also 
confirmed by the maintenance of glucose consumption 
levels from day 6, indicating no reduction in metabolism 
in the control cultures after the cultures had equilibrated. 
The control OC tissues did not show any increase in LDH, 
AP or GAG release after day 6, although MMP-2 levels 
did rise towards the end of the culture period. Moreover, 
the histological appearance of sections of the control 
tissues stained with H&E and safranin O, at days 0, 6 and 
20, indicated that the histo-morphology of the cartilage 
was maintained with good retention of GAGs. Hence, 
it could be inferred that no cell death or breakdown of 
the ECM occurred between days 6 and 20. In addition 
to the initial reduction in XTT conversion, the levels of 
glucose consumption, LDH release and GAG release took 
3, 6 and 1 d, respectively, to reach consistent levels. The 
procedure for harvesting the OC tissues, which involved 
coring of cylindrical plugs, would have led to mechanical 
damage to the cells and the ECM at the cut periphery. It 
is recognised that mechanical damage to healthy cartilage 
tissue can result in cell death, MMP up-regulation and GAG 
release (Correro-Shahgaldian et al., 2014). This inevitable 
damage would have led to some peripheral cell death 
(LDH release) and attempts by viable cells to remodel the 
damaged ECM during the initial period of culture which 
was the most likely explanation for the initially high levels 
of XTT conversion, glucose consumption, and AP release. 
Moreover, the collagen network in articular cartilage is 
under tension and has a characteristic orientation (Jeffrey et 
al., 1991). The harvesting of OC plugs would have severed 
the collagen fibres, leading to a loss of tension allowing 
proteoglycans (GAGs) in the periphery of the tissue to be 
released into the culture fluid.
 This is important when observing patterns of markers 
detected, as this initial culture period may give rise to 
erratic data. Allowing a time period for culture equilibration 
is an accepted technique used in many studies (Jacoby and 
Jayson, 1976; Fay et al., 2006; Tchetina et al., 2006), and 
should be routinely implemented during the monitoring 
of organ cultures. The day 20 XTT results showed that 
treatment of the OC tissues with both Triton X-100 and 
camptothecin, resulted in the loss of all bone cell viability 
and the most of cartilage cell viability, clearly showing that 
both treatments induced significant cell death within the 
OC tissues. The day 20 results of the LIVE/DEAD® cell 
stained cartilage tissue slices that had been treated with 
Triton X-100 and camptothecin were in agreement with 
the XTT data.
 A reduction in glucose consumption can indicate a 
drop in metabolism when cell death occurs, except during 
early apoptosis, although reduction of metabolism would 
be apparent after completion of apoptosis (Browne and Al-
Rubeai, 2011; Prill et al., 2014). The findings of this study 
are in agreement with this. The inclusion of 0.01 % Triton 
X-100 from day 6 onwards caused an immediate reduction 
in XTT conversion and glucose consumption (and therefore 
metabolism). This was most likely due to the detergent 
lysing the cells in the cartilage and bone. However, the 
camptothecin-induced reduction in glucose consumption 
was delayed, presumably representing a period of early 
cellular apoptosis during which glucose consumption still 
occurred as metabolism continued, followed by completion 
of apoptosis when cell death was complete and glucose 
consumption reduced.
 LDH is present in the cytosol and mitochondria of cells 
(Brooks et al., 1999). Since necrosis results in the loss of 
membrane integrity and subsequent release of LDH, the 
level of LDH in conditioned medium has been used as a 
marker of cell injury and death in monolayer cell culture 
(Racher et al., 1990; Wagner et al., 1991; Legrand et al., 
1992), and in organ culture of the intervertebral disc (Dudli 
et al., 2012). A rapid increase in LDH, and subsequent 
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immediate reduction in the OC tissues treated with Triton 
X-100, indicated a rapid and uncontrolled lysis of the 
majority of cells, and release of intracellular enzymes. It 
might be expected that apoptotic death would not lead to 
a rapid increase in LDH as chondrocyte apoptotic bodies 
have been reported to accumulate in the lacunae and 
interterritorial space (Hashimoto et al., 1998). However, 
an increase in LDH release was detected in OC cultures 
treated with camptothecin, after a delay, in this model. 
Since macrophages are not present in cartilage tissue, it can 
be hypothesised that the final phagocytic stage of apoptosis 
was not completed and that the contents (including LDH) 
of some of the apoptotic bodies were released.
 AP is a by-product of osteoblast activity so may 
indicate active and healthy bone, in addition to possible 
bone remodelling in the organ culture. However, no effects 
on AP release were recorded in the treated and untreated 
OC cultures. Early in the culture, following dissection, AP 
levels were very high throughout and any small changes in 
AP would have not been apparent. Later after a period of 
equilibration, the bone likely settled into a less active state 
where, even in the control group, AP levels were naturally 
low.
 The levels of GAGs are reduced in cartilage of osteo- 
and rheumatoid arthritis compared to normal cartilage 
(Hollander et al., 1991), indicating that GAGs are lost from 
the tissue as cartilage is degraded. The release of GAGs into 
conditioned medium has been assessed in organ cultures 
of full depth articular cartilage (Tchetina et al., 2006) and 
intervertebral discs (Korecki et al., 2007) to detect/quantify 
tissue degradation. The breakdown of cartilage and release 
of GAGs into the conditioned medium was therefore 
assessed as an indicator of tissue degradation in the present 
study. The OC tissues treated with Triton X-100, showed 
an immediate increase in GAG release into the conditioned 
medium, that might have been due to 1) the release of lyases 
and hydrolases from the intracellular contents as the cells 
lost membrane integrity, and 2) release of cell membrane 
bound GAG that would not necessarily be released from 
apoptotic bodies or (3) wash-out of proteoglycans from 
the cut-edge of the ECM as a result of disruption of the 
non-covalent interactions between aggrecan and long chain 
hyaluronic acid molecules in the cartilage. Detergents, 
including Triton X-100 have been reported to deplete 
tissues of proteoglycans, albeit at concentrations an order 
of magnitude greater than the 0.01 % used here (Vavken 
et al., 2009). There was no significant increase in GAG 
release in the OC tissue cultures treated with camptothecin. 
In cartilage, apoptotic bodies accumulate and remain in the 
lacunae and interterritorial space (Hashimoto et al., 1998). 
With no phagocytic cells present, the apoptotic bodies will 
eventually break down and release their contents (indicated 
by LDH results), but enzyme release may not have been 
adequate for subsequent ECM breakdown. In one of the 
two studies presented here, there was a non-significant 
small increase in GAG release after camptothecin 
treatment, indicating that perhaps slow release of ECM 
degrading enzymes had begun. The levels of MMP-2 and 
MMP-9 released into the conditioned medium at day 13 
and day 9, respectively, after camptothecin treatment, were 
higher than those detected in control cultures at the same 
points, although not as high as in the OC tissue cultures 
treated with Triton X-100. Both MMP-2 and MMP-9 have 
been shown to be expressed by chondrocytes and to play 
a role in osteoclast resorption during bone degradation 
(Murphy and Lee, 2005), and both are elevated in 
rheumatoid arthritic synovial fluid and tissues (Cawston 
and Young, 2010), suggesting that these MMPs might be 
expected to play a role in the breakdown of bone and/or 
cartilage in this model. It is of note that the relative level 
of active MMP-2 to pro-MMP-2 was higher at days 13 and 
16 in the camptothecin-treated cultures, and this agrees 
with findings that apoptosis can induce the activation of 
proMMP-2 (Preaux et al., 2002). Overall, however it was 
difficult to detect overt changes in MMP-9 and MMP-2 
using the zymography method in this study. It would have 
been advantageous to use specific ELISAs, had these been 
available for the porcine proteins.
 The general trends in levels of molecular markers 
of tissue viability were the same in both study repeats, 
although the levels of some markers varied. This highlights 
the need to monitor the day to day changes and general 
trends in marker levels to predict viability in individual 
cultures. Glucose consumption and LDH release have 
been used in combination as markers of tissue viability 
previously (Racher et al., 1990), and the data presented 
here support their use to predict loss of tissue viability 
in OC organ cultures. However, these two markers alone 
could not be used to indicate whether loss of tissue viability 
was due to necrosis or apoptosis, because the researcher 
would not know whether the changes were immediate or 
delayed. In this study we explored whether the inclusion 
of assays to assess ECM degradation (GAG release, 
MMP-2 and MMP-9 release) might indicate whether loss 
of tissue viability was by necrosis or apoptosis; however, 
it was possible that the increased levels of GAG release 
following Triton X-100 treatment, which was not seen with 
camptothecin-induced apoptosis were due to the detergent 
effect rather than an effect of the mode of cell death and 
this requires further investigation.
 More recently, lactate monitoring has been used in 
conjunction with glucose monitoring as a marker of 
anaerobic metabolism and hypoxia (Boero et al., 2011; 
Boero et al., 2014). Lactate is potentially a good marker 
to monitor in addition to those used in the research 
presented here, as it could be used to show whether 
oxygen was limiting in larger organ culture models. Other 
improvements which could be included in future would be 
to use other relevant markers of ECM degradation in OC 
organ culture, such as collagenase-cleaved type II collagen 
(Tchetina et al., 2006). Furthermore, the assays could be 
adapted to assess levels of different ECM markers for other 
types of organ and tissue culture.
 There have been a number of studies involving organ 
and tissue culture of different parts of the knee tissues, 
in which viability was not assessed (Jacoby and Jayson, 
1976; Hollander et al., 1991; Fay et al., 2006; Tchetina 
et al., 2006; Ashwell et al., 2008; Ashwell et al., 2013). 
The studies utilised minimal sample numbers, and any 
tissue destructive method of viability assessment was not 
possible due to restrictive sample numbers. The assessment 
of soluble markers in the conditioned medium would have 
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provided important information on tissue viability without 
the need to increase sample numbers.
 In vitro pre-clinical studies of novel therapies and 
devices are important initial steps in the clinical translation 
pathway (Anz et al., 2014). Many therapies and devices 
will not progress beyond this initial phase of development, 
and therefore efficient pre-clinical test methods are 
essential. The use of soluble markers to measure organ 
culture viability enables smaller sample numbers and 
reduced costs compared to the use of tissue destructive 
methods.
Conclusions
The data presented showed that both Triton X-100 and 
camptothecin induced loss of tissue viability in porcine 
OC organ culture models, but viability was maintained 
after an initial period of culture equilibration in untreated 
control cultures. Both glucose consumption and LDH 
release indicated a loss of viability, immediately following 
Triton X-100 treatment (necrosis induction), and after 
a delay following camptothecin treatment (apoptosis 
induction). The results showed that by using this approach, 
the viability of OC organ culture models can be quickly 
and easily monitored. The use of other molecular 
markers (for example markers of ECM degradation) for 
differentiation between apoptosis and necrosis requires 
further investigation.
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Discussion with Reviewers
Magali Cucchiarini: The goal of this study is to produce a 
convenient culture system of osteochondral tissue to easily 
assess viability based on the analysis of the production 
of soluble makers. The organ culture model is certainly 
pertinent as a simple system for future screening of drugs 
or of other therapeutic candidates. One weakness of the 
study is the use of non-clinically/-physiologically relevant 
molecules (Triton, camptothecin) and it would be necessary 
to test instead the effects of mediators such as those 
produced during pathological processes in the cartilage 
(inflammatory cytokines).
Authors: We agree entirely with this comment. We 
chose to use Triton X-100 and camptothecin to validate 
the approach as “positive controls” for cell death by 
necrosis and apoptosis. Now that the approach to utilise 
molecular markers in the conditioned medium as an 
indicator of loss of tissue viability has been established 
for the osteochondral organ cultures, it will be necessary 
to test more clinically relevant interventions, which for 
our research interests will include biomechanical loading 
and the impact of novel cartilage substitution therapies.
Benjamin Gantenbein: Why do the authors think the GAG 
release into the media was still increasing although they 
treated the cells with Triton X-100 or camptothecin after 
6 days and beyond? Why was the glucose consumption in 
the case of camptothecin not behaving the same way as 
with the treatment of Triton X-100 detergent?
Authors: The increase in GAG release into the culture 
medium in camptothecin and Triton X-100 treated cultures 
compared to control cultures beyond day 6 of culture might 
have been due to breakdown of aggrecan due to release/ 
activation of aggrecanases as observed for MMP-2. The 
camptothecin treated osteochondral plug cultures did 
indeed maintain higher levels of glucose consumption 
than the Triton X-100 treated cultures after day 6 which 
can be explained by the findings, from the LIVE/DEAD® 
cell imaging of cartilage slices which showed that at day 
20, there were still viable cells in the camptothecin treated 
cultures which were not found in the Triton X-100 treated 
cultures.
